From Apoptosis to Necroptosis: The Death Wishes to Cancer

被引:14
作者
Meng, Xianmei [1 ]
Dang, Tong [1 ]
Chai, Jianyuan [1 ,2 ,3 ]
机构
[1] Inner Mongolia Univ Sci & Technol, Inner Mongolia Engn Res Ctr Prevent & Treatment D, Inner Mongolia Inst Digest Dis, Affiliated Hosp 2,Baotou Med Coll, 30 Hudemulin Rd, Baotou 014030, Inner Mongolia, Peoples R China
[2] VA Long Beach Healthcare Syst, Lab Gastrointestinal Injury & Canc, Long Beach, CA USA
[3] Univ Calif Irvine, Coll Med, Irvine, CA 92717 USA
基金
中国国家自然科学基金;
关键词
apoptosis; necroptosis; autophagy; programmed cell death; cancer; BCL-2 FAMILY PROTEINS; CELL-DEATH; NOMENCLATURE COMMITTEE; SELF-CANNIBALISM; XENO-CANNIBALISM; CASP8; PROMOTER; NECROSIS; INHIBITOR; RECOMMENDATIONS; REQUIREMENT;
D O I
10.1177/10732748211066311
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA mutation is a common event in the human body, but in most situations, it is fixed right away by the DNA damage response program. In case the damage is too severe to repair, the programmed cell death system will be activated to get rid of the cell. However, if the damage affects some critical components of this system, the genetic scars are kept and multiply through mitosis, possibly leading to cancer someday. There are many forms of programmed cell death, but apoptosis and necroptosis represent the default and backup strategy, respectively, in the maintenance of optimal cell population as well as in cancer prevention. For the same reason, the ideal approach for cancer treatment is to induce apoptosis in the cancer cells because it proceeds 20 times faster than tumor cell proliferation and leaves no mess behind. Induction of necroptosis can be the second choice in case apoptosis becomes hard to achieve, however, necroptosis finishes the job at a cost-inflammation.
引用
收藏
页数:12
相关论文
共 85 条
[51]   Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target [J].
Mifflin, Lauren ;
Ofengeim, Dimitry ;
Yuan, Junying .
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (08) :553-571
[52]   Old and Novel Functions of Caspase-2 [J].
Miles, M. A. ;
Kitevska-Ilioski, T. ;
Hawkins, C. J. .
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 332, 2017, 332 :155-212
[53]   BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins [J].
Moldoveanu, Tudor ;
Czabotar, Peter E. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2020, 12 (04)
[54]   Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease [J].
Mormone, Elisabetta ;
Matarrese, Paola ;
Tinari, Antonella ;
Cannella, Milena ;
Maglione, Vittorio ;
Farrace, Maria Grazia ;
Piacentini, Mauro ;
Frati, Luigi ;
Malorni, Walter ;
Squitieri, Ferdinando .
JOURNAL OF NEUROCHEMISTRY, 2006, 98 (04) :1090-1099
[55]   FADD at the Crossroads between Cancer and Inflammation [J].
Mouasni, Sara ;
Tourneur, Lea .
TRENDS IN IMMUNOLOGY, 2018, 39 (12) :1036-1053
[56]   Apoptosis and Clearance of Apoptotic Cells [J].
Nagata, Shigekazu .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36, 2018, 36 :489-517
[57]   Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death [J].
Nakagawa, T ;
Shimizu, S ;
Watanabe, T ;
Yamaguchi, O ;
Otsu, K ;
Yamagata, H ;
Inohara, H ;
Kubo, T ;
Tsujimoto, Y .
NATURE, 2005, 434 (7033) :652-658
[58]   Death in the fast lane: what's next for necroptosis? [J].
Oberst, Andrew .
FEBS JOURNAL, 2016, 283 (14) :2616-2625
[60]   To Prime, or Not to Prime: That Is the Question [J].
Potter, Danielle S. ;
Letai, Anthony .
TARGETING CANCER, VOL 81, 2016, 2016, 81 :131-140